Bain Capital Public Equity Management II, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management II, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$725,000
-30.0%
659,350
-12.7%
0.05%
-40.0%
Q2 2020$1,035,000
+18.6%
755,536
-1.4%
0.08%
-21.6%
Q1 2020$873,000
-48.4%
765,986
+3.3%
0.10%
-36.2%
Q4 2019$1,691,000
+888.9%
741,573
+267.0%
0.16%
+900.0%
Q3 2019$171,000
-13.2%
202,0500.0%0.02%
-11.1%
Q2 2019$197,000202,0500.02%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders